drugset / Trial / NCT02707978

F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)

NCT02707978

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this research study is to evaluate tau distribution in the brain of subjects with: FTD caused by different genetic mutations, any mutation carriers (with or without symptoms), any non-mutation carrier, any sporadic FTD, normal controls.

Timeline

Start
2017-09-30
Primary completion
2020-09-30
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Flortaucipir F18 Diagnostic / imaging agent 240 mbq Intravenous
Subject Flortaucipir F18 Diagnostic / imaging agent 370 mbq Intravenous

Indications